Submissions are now open for the Eisai Golden Ticket 2025 Competition

READ MORE  ►

Kascaid Bio has closed a $2.3 million pre-seed round to develop interstitial fluid diagnostics

READ MORE  ►

CacheDNA  receives a $1.25M SBIR grant from NSF, in collaboration with Velocity Bio

READ MORE  ►

Dispatch Bio emerges from stealth with $216M to develop a universal approach to cancer immunotherapy

READ MORE  ►

Latent Labs introduces Latent-X, a no-code interface for generating lab-ready protein binders

READ MORE  ►

Serna Bio announces strategic collaboration with Chiesi Group to develop RNA-targeted small molecules for respiratory diseases

READ MORE  ►

New Partner Launch: Welcoming Opentrons to the MBC community

August 7 @ noon - 1pm
1030 Brittan Ave, San Carlos

We are excited to announce our new partnership with Opentrons Labworks! Join us for an informative presentation on how Opentrons' Flex system supports automated liquid handling and assists with NGS library prep, PCR, protein purification, nucleic acid extraction, and sample prep.

REGISTER  ►

Fueling Scientific Progress in Cell Gene Therapy and Advanced Therapy Solutions with Sartorius

August 14 @ noon - 1pm
1030 Brittan Ave, San Carlos

Join Zahra Alvandi and Ashlee Sun from Sartorius Advanced Therapies division for an informative and engaging talk on Cell Gene Therapy and advanced therapy solutions. This talk will cover media and buffers, chromatography solutions, plasmid cloning and much more!

REGISTER  ►

MBC BioLabs Oncology Innovation Forum

September 18 @ 3:30 - 7:30pm
1030 Brittan Ave, San Carlos

We’re excited to host our third Innovation Forum, spotlighting breakthrough oncology startups and bringing together a curated group of investors, industry leaders, and MBC BioLabs founders.
This invitation-only event will feature investor insights, startup presentations from companies like Alessa Therapeutics, DeepSeq.AI, and Serna Bio, a poster session showcasing emerging technologies, and a networking reception with leaders across the life sciences ecosystem.

REGISTER  ►

Lace Up for the J.P. Morgan Corporate Challenge — Join the MBC BioLabs Team!

September 3rd @ 6:45pm
Chase Center

Get ready to step out of the lab and onto the course! The J.P. Morgan Corporate Challenge San Francisco is coming up, and we’d love for you to join fellow residents and the broader MBC BioLabs community for a fun, energizing evening. We'll have the opportunity to spend quality time outside of the lab, compete in a 3.5-mile race along the Embarcadero, and celebrate afterward at the Chase Center.

Register for the MBC BioLabs team using the link below (we're working on MBC Run Club shirts!) or feel free to round up your colleagues and register your own company's team. We hope to see you out there!

REGISTER  ►

Reprogram Biosciences is a pioneering biotechnology company leveraging in vivo reprogramming to transform cancer cells into immune functioning cells directly within solid tumors—turning tumors into allies in the fight against cancer. Their innovative approach promises safer, off the shelf, and more cost effective immunotherapy solutions by rewiring cell identity within the tumor microenvironment.

We warmly welcome co-founder and CEO Rustam Esanov, co-founder and COO Eziz Kuliyev, and Head of Research Angela Yang to our 1030 Brittan community in San Carlos!

LEARN MORE  ►